European multicenter evaluation of survival for patients with hepatocellular carcinoma (HCC) treated by radioembolization with 90y-labeled resin microspheres

被引:3
|
作者
Sangro, B.
Carpanese, L.
Cianni, R.
Golfieri, R.
Gasparini, D.
Ezzidin, S.
Hoffman, R.
Fiore, F.
机构
[1] Univ Navarra Clin, Liver Unit, Pamplona, Spain
[2] CIBEREHD, Pamplona, Spain
[3] IFO Regina Elena Natl Canc Inst, Rome, Italy
[4] Osped SM Goretti, Latina, Italy
[5] St Orsola Marcello Malpighi Hosp, Bologna, Italy
[6] Azienda Osped Santa Maria Misericordia, Udine, Italy
[7] Univ Klin Bonn, Bonn, Germany
[8] Univ Munich, LMU Klinikum, Munich, Germany
[9] G Pascale Canc Inst, Naples, Italy
关键词
D O I
10.1200/jco.2010.28.15_suppl.4027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4027
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [41] Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival
    Hilgard, Philip
    Hamami, Monia
    El Fouly, Amr
    Scherag, Andre
    Mueller, Stefan
    Ertle, Judith
    Heusner, Till
    Cicinnati, Vito R.
    Paul, Andreas
    Bockisch, Andreas
    Gerken, Guido
    Antoch, Gerald
    HEPATOLOGY, 2010, 52 (05) : 1741 - 1749
  • [42] Radioembolization with yttrium-90 glass microspheres for patients with hepatocellular carcinoma: a review
    Schlaak, Joerg Friedrich
    HEPATIC ONCOLOGY, 2014, 1 (04) : 387 - 393
  • [43] 90Y TOF-PET based EUD reunifies patient survival prediction in resin and glass microspheres radioembolization of HCC tumours
    d'Abadie, P.
    Walrand, S.
    Hesse, M.
    Lhommel, R.
    Jamar, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S580 - S580
  • [44] 90Y TOF-PET based EUD reunifies patient survival prediction in resin and glass microspheres radioembolization of HCC tumours
    D'Abadie P.
    Hesse M.
    Jamar F.
    Lhommel R.
    Walrand S.
    2018, IOP Publishing Ltd (63):
  • [45] 90Y TOF-PET based EUD reunifies patient survival prediction in resin and glass microspheres radioembolization of HCC tumours
    d'Abadie, P.
    Hesse, M.
    Jamar, F.
    Lhommel, R.
    Walrand, S.
    PHYSICS IN MEDICINE AND BIOLOGY, 2018, 63 (24):
  • [46] Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
    Garin, Etienne
    Pallard, Xavier
    Edeline, Julien
    GASTROENTEROLOGY, 2017, 152 (06) : 1624 - +
  • [47] A Retrospective Comparative Analysis of the Effect of Y90-radioembolization on the Survival of Patients with Unresectable Hepatocellular Carcinoma
    D'Avola, Delia
    Inarrairaegui, Mercedes
    Bilbao, Jose I.
    Martinez-Cuesta, Antonio
    Alegre, Felix
    Herrero, Jose I.
    Quiroga, Jorge
    Prieto, Jesus
    Sangro, Bruno
    HEPATO-GASTROENTEROLOGY, 2009, 56 (96) : 1683 - 1688
  • [48] Patterns of Targeted Hepatic Injury in Patients with Hepatocellular Carcinoma Treated with Ablative Y-90 Radioembolization
    Lewis, Jason
    Toskich, Beau
    Nakhleh, Raouf
    Montazeri, Seyed Ali
    De la Garza-Ramos, Cynthia
    Krishna, Murli
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1128 - 1129
  • [49] Use of dose-volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres
    Coskun, Nazim
    Kartal, Mehmet Oguz
    Kartal, Aysenur Sinem
    Cayhan, Velihan
    Ozdemir, Mustafa
    Canyigit, Murat
    Ozdemir, Elif
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (07) : 525 - 533
  • [50] A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC).
    Somasundaram, Ashwin
    Helft, Paul R.
    Harris, William Proctor
    Sanoff, Hanna Kelly
    Johnson, Guy E.
    Yu, Menggang
    Johnson, Matthew
    O'Neil, Bert
    Mcree, Autumn Jackson
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 534 - 534